Anna Haemel is a Dermatology physician affiliated with University of California, San Francisco. OpenAlex indexes 82 publications with 1,601 citations (h-index 17); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1701 Divisadero St
3rd Floor
San Francisco, CA 941153011
Telephone
415-353-7800Registry record last updated 27 Jul 2011.
Clinical trials
- Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Autologous Polyclonal Tregs for Lupus
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- CSL BehringProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
26.6%Tetracycline-class Drug10%Doxycycline Hyclate100%Part D≥47 patientsAzole Antifungal7.5%Ketoconazole100%Part D≥63 patients+ 3 more classes in this area
Dermatology
17.5%Corticosteroid7.3%Triamcinolone Acetonide100%Part D≥61 patientsInterleukin-4 Receptor alpha Antagonist3.3%Dupixent Pen64%Dupixent Syringe36%Part D<11 patients+ 6 more classes in this area
Cardiovascular
11.2%Arteriolar Vasodilator4.4%Minoxidil100%Part D≥23 patientsCorticosteroid3%Fluocinonide100%Part D≥34 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”